Pessary ‘no better than progesterone’ for preterm birth prevention
Cervical pessary is no better than vaginal progesterone for preventing preterm birth in women with singleton pregnancies and a short cervix of ≤35mm, according to…
Specialist Updates
In-depth coverage of specialist medicine
Conventional IVF ‘still reliable’ with single oocyte retrieval
Limited oocyte availability should not dictate the use of intracytoplasmic sperm injection (ICSI), according to Italian doctors, who say conventional IVF is reliable even when…
Why simple hysterectomy is better for low-risk cervical cancer
Women with low-risk cervical cancer can undergo simple instead of radical hysterectomy, according to Canadian-led doctors who say the procedures yield similar oncological outcomes. The…
Watch for poor bone health in teens after bariatric surgery, doctors say
Roux-en-Y gastric bypass and sleeve gastrectomy are “highly effective” and safe in under-18s with class II or III obesity but can lead to poorer bone…
Pre-eclampsia almost doubles vascular dementia risk in later life: study
Women with a history of pre-eclampsia are nearly twice as likely to develop vascular dementia than those who had normotensive pregnancies, data from over two…
Doctors call for inquiry into rising perinatal deaths
A leading obstetrician is calling for a national inquiry into maternity care after new data revealed the perinatal death rate in Queensland had jumped by…
Secondary primary malignancies ‘rare’ after CAR T-cell immunotherapy
The incidence of secondary primary malignancy after anti-CD19 chimeric antigen receptor T-cell immunotherapy is very low, according to a study in Nature Medicine. US researchers…
Offer compression sleeves to prevent breast cancer–related arm lymphoedema: new guidance
Patients at risk of developing arm lymphoedema after breast cancer treatment should be offered prophylactic compression sleeves, according to world-first guidance. Axillary reverse mapping and…
‘We did not expect these results’: Testosterone therapy linked to higher fracture risk
Testosterone treatment may increase fracture risk in middle-aged and older men with hypogonadism, according to new research that contradicts conventional wisdom. While exogenous testosterone has…
Alpha therapy a ‘viable option’ for metastatic castration-resistant prostate cancer
Targeted alpha therapy is safe and effective for treating metastatic castration-resistant prostate cancer when other anticancer agents have failed, show results from the largest trial…
